Azora Therapeutics Balance Sheet
NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Azora Therapeutics financial position
At the end of fiscal 2025, Azora Therapeutics reported total assets of $6.7 million, up 17.9% from a year earlier against total liabilities of $1.4 million. Shareholders' equity stood at $5.3 million, or 79.1% of assets. The company held $5.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.42, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Azora Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20252025-09-30 | FY 20242024-12-31 | FY 20242024-09-30 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.88M | 4.61M | 3.75M | 5.20M | 2.83M | 4.00M | 6.06M | 4.40M | 6.78M | 3.87M |
| Total Current Assets | 6.18M | 5.01M | 4.06M | 5.62M | 3.20M | 4.78M | 6.46M | 5.14M | 7.67M | 4.69M |
| Property, Plant & Equipment | — | — | — | — | — | 50.42K | 58.15K | — | — | — |
| Goodwill | — | — | — | — | — | 248.97K | 248.97K | — | — | — |
| Intangible Assets | 3.00K | 2.92K | 3.35K | 3.49K | 3.91K | 4.48K | 5.04K | 5.61K | 6.17K | 6.74K |
| Total Assets | 6.67M | 5.66M | 5.04M | 6.71M | 4.74M | 5.73M | 7.47M | 5.49M | 7.68M | 4.70M |
| Accounts Payable | 655.00K | 556.28K | 250.13K | 318.12K | 103.33K | 276.41K | 286.19K | 648.74K | 190.20K | 99.67K |
| Total Current Liabilities | 1.40M | 1.15M | 975.86K | 829.05K | 653.08K | 1.79M | 2.72M | 1.51M | 539.05K | 257.97K |
| Total Liabilities | 1.40M | 1.15M | 975.86K | 829.05K | 653.08K | 2.46M | 3.97M | 1.51M | 539.05K | 257.97K |
| Shareholders' Equity | 5.28M | 4.50M | 4.07M | 5.88M | 4.08M | 3.28M | 3.51M | 3.99M | 7.14M | 4.44M |
| Retained Earnings | -89.97M | -87.98M | -82.00M | -79.92M | -68.80M | -63.67M | -50.94M | -31.52M | -20.63M | -12.04M |
| Net Cash (Debt) | 5.88M | 4.61M | 3.75M | 5.20M | 2.83M | 4.00M | 6.06M | 4.40M | 6.78M | 3.87M |
| Shares Outstanding | 1.11M | 23.84M | 258.83K | 6.41M | 1.66M | 1.07M | 20.95M | 14.39M | 10.37M | 6.86M |
This table shows 10 annual periods of Azora Therapeutics's balance sheet, from FY 2025 back to FY 2018, across 13 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a balance sheet?